Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Apotex Europe B.V., Pfizer Europe MA EEIG, Glenmark Pharmaceuticals s.r.o., against the decision of the State Institute for Drug Control from 30. 10. 2018, under the no. SUKLS110938/2014 - I. Under article 90 paragraph 4 in connection with article 66 paragraph 1 letter f) of the Administrative Code the operative part 2, 3, 4, 5, 15, 18, 21, 23, 24, 27, 28, 29, 30, 31, 32, 34, 35, 36, 38, 51, 52, 53 and 54 of the decision under appeal is dismissed and the proceedings are terminated. II. Under aticle 90 paragraph 5 of the Administrative Code the appeal is dismissed and the rest of the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Celltrion Healthcare Hungary Kft., against the decision of the State Institute for Drug Control from 22. 9. 2017, under the no. SUKLS170429/2017 - The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Biogen Netherlands B.V., against the decision of the State Institute for Drug Control from 14. 1. 2020, under the no. SUKLS81849/2014 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Celltrion Healthcare Hungary Kft., against the decision of the State Institute for Drug Control from 21. 12. 2018, under the no. SUKLS72056/2018 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, against the decision of the State Institute for Drug Control from 10. 8. 2017, under the no. SUKLS66619/2017 - 

The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant GENZYME EUROPE B.V., against the decision of the State Institute for Drug Control from 22. 9. 2017, under the no. SUKLS64046/2017 - 

The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 4. 6. 2018, under the no. SUKLS225773/2018 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)